SOLIGENIX, INC. Public Float
SOLIGENIX, INC. (SNGX) had Public Float of $4.59 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $4.59M.
- 2024-06-30: Entity Public Float $3.98M.
- 2023-06-30: Entity Public Float $6.85M.
- 2022-06-30: Entity Public Float $25.73M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.59M 10-K · filed 2026-03-31 |
| 2024-06-30 | $3.98M 10-K · filed 2025-03-21 |
| 2023-06-30 | $6.85M 10-K · filed 2024-03-15 |
| 2022-06-30 | $25.73M 10-K · filed 2023-03-31 |
| 2021-06-30 | $39.98M 10-K · filed 2022-03-29 |
| 2020-06-30 | $57.30M 10-K · filed 2021-03-30 |
| 2019-06-28 | $9.58M 10-K · filed 2020-03-30 |
| 2018-06-30 | $8.44M 10-K · filed 2019-03-26 |
| 2017-06-30 | $11.54M 10-K · filed 2018-03-15 |
| 2016-06-30 | $18.59M 10-K · filed 2017-03-27 |
| 2015-06-30 | $22.06M 10-K · filed 2016-03-24 |
| 2014-06-30 | $26.53M 10-K · filed 2015-03-25 |
| 2014-03-21 | $29.25M 10-K · filed 2014-03-26 |
| 2013-02-22 | $14.84B 10-K · filed 2013-02-26 |
| 2012-03-21 | $4.42M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |